6-7181922-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -10 ACMG points: 0P and 10B. BP4_StrongBP6_ModerateBS2
The NM_001003699.4(RREB1):c.11G>A(p.Ser4Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000678 in 1,614,252 control chromosomes in the GnomAD database, including 7 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0028 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00046 ( 5 hom. )
Consequence
RREB1
NM_001003699.4 missense
NM_001003699.4 missense
Scores
18
Clinical Significance
Conservation
PhyloP100: 0.860
Genes affected
RREB1 (HGNC:10449): (ras responsive element binding protein 1) The protein encoded by this gene is a zinc finger transcription factor that binds to RAS-responsive elements (RREs) of gene promoters. It has been shown that the calcitonin gene promoter contains an RRE and that the encoded protein binds there and increases expression of calcitonin, which may be involved in Ras/Raf-mediated cell differentiation. Multiple transcript variants encoding several different isoforms have been found for this gene. [provided by RefSeq, Dec 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -10 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.006005436).
BP6
Variant 6-7181922-G-A is Benign according to our data. Variant chr6-7181922-G-A is described in ClinVar as [Benign]. Clinvar id is 791534.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High AC in GnomAd4 at 420 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RREB1 | NM_001003699.4 | c.11G>A | p.Ser4Asn | missense_variant | 4/13 | ENST00000379938.7 | NP_001003699.1 | |
RREB1 | NM_001003698.4 | c.11G>A | p.Ser4Asn | missense_variant | 4/12 | NP_001003698.1 | ||
RREB1 | NM_001168344.2 | c.11G>A | p.Ser4Asn | missense_variant | 4/12 | NP_001161816.1 | ||
RREB1 | NM_001003700.2 | c.11G>A | p.Ser4Asn | missense_variant | 4/12 | NP_001003700.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00274 AC: 417AN: 152252Hom.: 2 Cov.: 32
GnomAD3 genomes
AF:
AC:
417
AN:
152252
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000808 AC: 203AN: 251368Hom.: 0 AF XY: 0.000670 AC XY: 91AN XY: 135852
GnomAD3 exomes
AF:
AC:
203
AN:
251368
Hom.:
AF XY:
AC XY:
91
AN XY:
135852
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000462 AC: 675AN: 1461882Hom.: 5 Cov.: 31 AF XY: 0.000441 AC XY: 321AN XY: 727244
GnomAD4 exome
AF:
AC:
675
AN:
1461882
Hom.:
Cov.:
31
AF XY:
AC XY:
321
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00276 AC: 420AN: 152370Hom.: 2 Cov.: 32 AF XY: 0.00264 AC XY: 197AN XY: 74510
GnomAD4 genome
AF:
AC:
420
AN:
152370
Hom.:
Cov.:
32
AF XY:
AC XY:
197
AN XY:
74510
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
46
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
130
Asia WGS
AF:
AC:
9
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
RREB1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 25, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;T;.;.;.;.;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
.;T;T;T;.;T;T;T
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
N;.;N;.;.;N;N;.
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N;D;N;N;N
REVEL
Benign
Sift
Benign
T;T;T;T;.;T;T;T
Sift4G
Benign
T;T;T;T;.;T;T;T
Polyphen
B;.;B;.;.;B;B;.
Vest4
MVP
MPC
0.53
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at